Contact
Please use this form to send email to PR contact of this press release:
OncoMed Doses First Patient in Phase 1b Portion of anti-TIGIT Clinical Trial
TO:
Please use this form to send email to PR contact of this press release:
OncoMed Doses First Patient in Phase 1b Portion of anti-TIGIT Clinical Trial
TO: